NSE › Healthcare

RPG Life Sciences Limited (RPGLIFE)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹2,756.80-6.14%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
₹177 cr
Revenue YoY
+23.6%
Net profit
₹30 cr
Profit YoY
-74.5%
EPS
₹6.74
EPS estimate
₹5.68
Net margin
16.9%

EPS came in at 6.74 against a street estimate of 5.68 — a beat of 18.7%.

Key statistics

Market cap
₹4,598 cr
P/E
38.5
Forward P/E
0.0
P/B
7.56
Book value
₹366.01
EPS (TTM)
₹72.25
52-week high
₹3,082.00
52-week low
₹1,716.04
50-day MA
₹2,473.02
200-day MA
₹2,230.87
Beta
-0.21

Analyst view

with an average price target of ₹478.00.

Shareholding

Promoters
75.30%
Institutions
5.55%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for RPG Life Sciences Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedCipla LimitedZydus Lifesciences LimitedLupin LimitedMax Healthcare Institute LimitedMankind Pharma LtdLaurus Labs LimitedLenskart Solutions LtdDr. Reddy's Laboratories Limited

Data updated 2026-08-05.